Join Growin Stock Community!
Back to GEN.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

operating-expenses-chart

GEN Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q3'26 (2026-01-02), GEN reported R&D Expenses of USD 96M and SG&A Expenses of USD 377M. This marks a sequential decrease in R&D spending from the previous quarter's USD 100M, while SG&A Expenses saw a slight increase from USD 357M in Q2'26. Over the period from Q4'23 to Q3'26, SG&A Expenses have consistently represented the dominant portion of GEN's operating expenses, with a notable spike to USD 580M in Q2'24 before stabilizing in the USD 226M–377M range. R&D Expenses have remained comparatively stable, mostly fluctuating between USD 77M and USD 109M, with a sharp increase in Q1'26. Overall, the chart reveals that while R&D spending has shown moderate variability, SG&A Expenses have experienced more pronounced volatility, particularly in early fiscal 2024.